In a rat hepatoma model, it has been demonstrated that exogenous addition of EDN1 enhances hepatoma cell growth in a dose‐dependent manner, whereas an endothelin receptor antagonist inhibits tumor growth.99 The gene discussed is EDN1; the disease is hepatocellular carcinoma.